{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:23:04Z","timestamp":1792110184455,"version":"4.4.0"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T00:00:00Z","timestamp":1733961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11910-024-01387-2","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T08:40:35Z","timestamp":1733992835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pathophysiology and Management of Refractory Trigeminal Neuralgia"],"prefix":"10.1007","volume":"25","author":[{"given":"Jennifer I.","family":"Stern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rushna","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7802-7172","authenticated-orcid":false,"given":"Chia-Chun","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9382-0897","authenticated-orcid":false,"given":"Carrie E.","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,12]]},"reference":[{"issue":"1","key":"1387_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0333102417738202","volume":"38","author":"Headache Classification Committee of the International Headache Society (IHS)","year":"2018","unstructured":"Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1\u2013211.","journal-title":"Cephalalgia"},{"key":"1387_CR2","first-page":"665","volume":"3","author":"C Robertson","year":"2021","unstructured":"Robertson C. Cranial neuralgias. Continuum (Minneap Minn). 2021;3:665\u201385.","journal-title":"Continuum (Minneap Minn)"},{"key":"1387_CR3","doi-asserted-by":"publisher","first-page":"e155","DOI":"10.1016\/j.wneu.2018.06.145","volume":"118","author":"CM Honey","year":"2018","unstructured":"Honey CM, Kaufmann AM. Trigeminal neuralgia due to vertebrobasilar artery compression. World Neurosurg. 2018;118:e155\u201360.","journal-title":"World Neurosurg"},{"issue":"15","key":"1387_CR4","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1212\/01.wnl.0000326598.83183.04","volume":"71","author":"G Gronseth","year":"2008","unstructured":"Gronseth G, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the quality standards subcommittee of the American academy of neurology and the European federation of neurological societies. Neurology. 2008;71(15):1183\u201390.","journal-title":"Neurology"},{"issue":"6","key":"1387_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3949\/ccjm.90a.22052","volume":"90","author":"MS Chong","year":"2023","unstructured":"Chong MS, Bahra A, Zakrzewska JM. Guidelines for the management of trigeminal neuralgia. Cleve Clin J Med. 2023;90(6):355\u201362.","journal-title":"Cleve Clin J Med"},{"issue":"1","key":"1387_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1129-2377-15-34","volume":"15","author":"G Di Stefano","year":"2014","unstructured":"Di Stefano G, et al. Natural history and outcome of 200 outpatients with classical trigeminal neuralgia treated with carbamazepine or oxcarbazepine in a tertiary centre for neuropathic pain. J Headache Pain. 2014;15(1):34.","journal-title":"J Headache Pain"},{"key":"1387_CR7","first-page":"461","volume":"20","author":"J Liebel","year":"2001","unstructured":"Liebel J, Menger N, Langohr H. Oxcarbazepine in der Behandlung der Trigeminusneuralgie. Nervenheilkunde. 2001;20:461\u20135.","journal-title":"Nervenheilkunde"},{"issue":"6","key":"1387_CR8","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/ene.13950","volume":"263","author":"L Bendtsen","year":"2019","unstructured":"Bendtsen L et al. (2019) European academy of neurology guideline on trigeminal neuralgia. Eur J Neurol. 26(6):831\u2013849.\u00a0","journal-title":"Eur J Neurol"},{"issue":"10","key":"1387_CR9","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1468-1331.2008.02185.x","volume":"15","author":"G Cruccu","year":"2008","unstructured":"Cruccu G, et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol. 2008;15(10):1013\u201328.","journal-title":"Eur J Neurol"},{"issue":"Pt 12","key":"1387_CR10","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1093\/brain\/124.12.2347","volume":"124","author":"S Love","year":"2001","unstructured":"Love S, Coakham HB. Trigeminal neuralgia: pathology and pathogenesis. Brain. 2001;124(Pt 12):2347\u201360.","journal-title":"Brain"},{"issue":"2","key":"1387_CR11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1227\/00006123-199408000-00017","volume":"35","author":"DA Hilton","year":"1994","unstructured":"Hilton DA, et al. Pathological findings associated with trigeminal neuralgia caused by vascular compression. Neurosurg. 1994;35(2):299\u2013303.","journal-title":"Neurosurg"},{"issue":"1","key":"1387_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s10194-019-0969-0","volume":"20","author":"G Di Stefano","year":"2019","unstructured":"Di Stefano G, Maarbjerg S, Truini A. Trigeminal neuralgia secondary to multiple sclerosis: from the clinical picture to the treatment options. J Headache Pain. 2019;20(1):20.","journal-title":"J Headache Pain"},{"issue":"1","key":"1387_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/00002508-200201000-00002","volume":"18","author":"M Devor","year":"2002","unstructured":"Devor M, Amir R, Rappaport ZH. Pathophysiology of trigeminal neuralgia: the ignition hypothesis. Clin J Pain. 2002;18(1):4\u201313.","journal-title":"Clin J Pain"},{"issue":"8","key":"1387_CR14","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1177\/0333102419897623","volume":"40","author":"G Di Stefano","year":"2020","unstructured":"Di Stefano G, et al. Familial trigeminal neuralgia - a systematic clinical study with a genomic screen of the neuronal electrogenisome. Cephalalgia. 2020;40(8):767\u201377.","journal-title":"Cephalalgia"},{"issue":"5","key":"1387_CR15","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3171\/2023.2.JNS23274","volume":"139","author":"B Dong","year":"2023","unstructured":"Dong B, Xu R, Lim M. The pathophysiology of trigeminal neuralgia: a molecular review. J Neurosurg. 2023;139(5):1471\u20139.","journal-title":"J Neurosurg"},{"key":"1387_CR16","doi-asserted-by":"publisher","first-page":"174480692110161","DOI":"10.1177\/17448069211016139","volume":"17","author":"MA Mannerak","year":"2021","unstructured":"Mannerak MA, Lashkarivand A, Eide PK. Trigeminal neuralgia and genetics: a systematic review. Mol Pain. 2021;17:17448069211016139.","journal-title":"Mol Pain"},{"key":"1387_CR17","doi-asserted-by":"publisher","first-page":"174480692090189","DOI":"10.1177\/1744806920901890","volume":"16","author":"E Gambeta","year":"2020","unstructured":"Gambeta E, Chichorro JG, Zamponi GW. Trigeminal neuralgia: an overview from pathophysiology to pharmacological treatments. Mol Pain. 2020;16:1744806920901890.","journal-title":"Mol Pain"},{"key":"1387_CR18","doi-asserted-by":"publisher","first-page":"338","DOI":"10.2119\/molmed.2016.00131","volume":"22","author":"BS Tanaka","year":"2016","unstructured":"Tanaka BS, et al. A gain-of-function mutation in Nav1.6 in a case of trigeminal neuralgia. Mol Med. 2016;22:338\u201348.","journal-title":"Mol Med"},{"issue":"6","key":"1387_CR19","doi-asserted-by":"publisher","first-page":"e1117","DOI":"10.1097\/PR9.0000000000001117","volume":"8","author":"C Ostertag","year":"2023","unstructured":"Ostertag C, et al. Heightened presence of inflammatory mediators in the cerebrospinal fluid of patients with trigeminal neuralgia. Pain Rep. 2023;8(6):e1117.","journal-title":"Pain Rep"},{"issue":"5","key":"1387_CR20","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3390\/biomedicines10050998","volume":"10","author":"T Svedung Wettervik","year":"2022","unstructured":"Svedung Wettervik T, et al. Cerebrospinal fluid in classical trigeminal neuralgia: an exploratory study on candidate biomarkers. Biomedicines. 2022;10(5):998.","journal-title":"Biomedicines"},{"issue":"1","key":"1387_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/24740527.2019.1709163","volume":"4","author":"TL Doshi","year":"2020","unstructured":"Doshi TL, et al. Biomarkers in temporomandibular disorder and trigeminal neuralgia: a conceptual framework for understanding chronic pain. Can J Pain. 2020;4(1):1\u201318.","journal-title":"Can J Pain"},{"issue":"3","key":"1387_CR22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3171\/jns.2002.96.3.0527","volume":"96","author":"EC Tyler-Kabara","year":"2002","unstructured":"Tyler-Kabara EC, et al. Predictors of outcome in surgically managed patients with typical and atypical trigeminal neuralgia: comparison of results following microvascular decompression. J Neurosurg. 2002;96(3):527\u201331.","journal-title":"J Neurosurg"},{"issue":"4","key":"1387_CR23","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3171\/2008.9.17660","volume":"110","author":"JP Miller","year":"2009","unstructured":"Miller JP, et al. Predictors of long-term success after microvascular decompression for trigeminal neuralgia. J Neurosurg. 2009;110(4):620\u20136.","journal-title":"J Neurosurg"},{"issue":"5\u20136","key":"1387_CR24","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.wneu.2012.01.040","volume":"79","author":"H Zhang","year":"2013","unstructured":"Zhang H, et al. The long-term outcome predictors of pure microvascular decompression for primary trigeminal neuralgia. World Neurosurg. 2013;79(5\u20136):756\u201362.","journal-title":"World Neurosurg"},{"issue":"11","key":"1387_CR25","doi-asserted-by":"publisher","first-page":"7349","DOI":"10.1007\/s00330-024-10775-8","volume":"34","author":"S Li","year":"2024","unstructured":"Li S et al. Predicting long-term outcomes in patients with classical trigeminal neuralgia following microvascular decompression with an MRI-based radiomics nomogram: a multicentre study. Eur Radiol, 2024;34(11):7349\u20137361.","journal-title":"Eur Radiol"},{"key":"1387_CR26","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.nicl.2017.06.017","volume":"15","author":"PS Hung","year":"2017","unstructured":"Hung PS, et al. Predicting pain relief: use of pre-surgical trigeminal nerve diffusion metrics in trigeminal neuralgia. Neuroimage Clin. 2017;15:710\u20138.","journal-title":"Neuroimage Clin"},{"issue":"8","key":"1387_CR27","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1007\/s00234-023-03155-4","volume":"65","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, et al. Predictive value of preoperative magnetic resonance imaging structural and diffusion indices for the results of trigeminal neuralgia microvascular decompression surgery. Neuroradiology. 2023;65(8):1255\u201361.","journal-title":"Neuroradiology"},{"issue":"6","key":"1387_CR28","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.3171\/2014.12.JNS142086","volume":"123","author":"Y Duan","year":"2015","unstructured":"Duan Y, et al. Degree of distal trigeminal nerve atrophy predicts outcome after microvascular decompression for type 1a trigeminal neuralgia. J Neurosurg. 2015;123(6):1512\u20138.","journal-title":"J Neurosurg"},{"issue":"1","key":"1387_CR29","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12883-021-02323-4","volume":"21","author":"H Danyluk","year":"2021","unstructured":"Danyluk H, et al. The thalamus in trigeminal neuralgia: structural and metabolic abnormalities, and influence on surgical response. BMC Neurol. 2021;21(1):290.","journal-title":"BMC Neurol"},{"key":"1387_CR30","doi-asserted-by":"publisher","first-page":"716500","DOI":"10.3389\/fneur.2021.716500","volume":"12","author":"H Danyluk","year":"2021","unstructured":"Danyluk H, et al. Pre-operative limbic system functional connectivity distinguishes responders from non-responders to surgical treatment for trigeminal neuralgia. Front Neurol. 2021;12:716500.","journal-title":"Front Neurol"},{"key":"1387_CR31","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1016\/j.wneu.2024.03.131","volume":"186","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, et al. Revisiting the efficacy of redo microvascular decompression for trigeminal neuralgia. World Neurosurg. 2024;186:e335\u201341.","journal-title":"World Neurosurg"},{"issue":"1","key":"1387_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1129-2377-15-65","volume":"15","author":"H Zhang","year":"2014","unstructured":"Zhang H, et al. Two doses of botulinum toxin type A for the treatment of trigeminal neuralgia: observation of therapeutic effect from a randomized, double-blind, placebo-controlled trial. J Headache Pain. 2014;15(1):65.","journal-title":"J Headache Pain"},{"issue":"18","key":"1387_CR33","doi-asserted-by":"publisher","first-page":"e15167","DOI":"10.1097\/MD.0000000000015167","volume":"98","author":"J Cheng","year":"2019","unstructured":"Cheng J, et al. Repeat microvascular decompression for patients with persistent or recurrent trigeminal neuralgia: prognostic factors and long-term outcomes. Med (Baltim). 2019;98(18):e15167.","journal-title":"Med (Baltim)"},{"issue":"12","key":"1387_CR34","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1007\/s00701-023-05877-z","volume":"165","author":"G Hatipoglu Majernik","year":"2023","unstructured":"Hatipoglu Majernik G, et al. Microsurgical posterior fossa re-exploration for recurrent trigeminal neuralgia after previous microvascular decompression: common grounds-scarring, deformation, and the piston effect. Acta Neurochir (Wien). 2023;165(12):3877\u201385.","journal-title":"Acta Neurochir (Wien)"},{"key":"1387_CR35","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.wneu.2021.11.129","volume":"158","author":"L Jiao","year":"2022","unstructured":"Jiao L, et al. A systematic review of repeat microvascular decompression for recurrent or persistent trigeminal neuralgia. World Neurosurg. 2022;158:226\u201333.","journal-title":"World Neurosurg"},{"issue":"4","key":"1387_CR36","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1111\/head.14505","volume":"63","author":"A Munoz-Vendrell","year":"2023","unstructured":"Munoz-Vendrell A, et al. Oral lacosamide for the treatment of refractory trigeminal neuralgia: a retrospective analysis of 86 cases. Headache. 2023;63(4):559\u201364.","journal-title":"Headache"},{"issue":"6","key":"1387_CR37","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1002\/ejp.1192","volume":"22","author":"A Sanchez-Larsen","year":"2018","unstructured":"Sanchez-Larsen A, et al. Assessment of efficacy and safety of eslicarbazepine acetate for the treatment of trigeminal neuralgia. Eur J Pain. 2018;22(6):1080\u20137.","journal-title":"Eur J Pain"},{"issue":"5","key":"1387_CR38","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1177\/10600280221120457","volume":"57","author":"B Yu","year":"2023","unstructured":"Yu B, et al. Effectiveness, Safety, and predictors of response to 5% lidocaine-medicated plaster for the treatment of patients with trigeminal neuralgia: a retrospective study. Ann Pharmacother. 2023;57(5):527\u201334.","journal-title":"Ann Pharmacother"},{"issue":"5","key":"1387_CR39","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1111\/head.14693","volume":"64","author":"J Robblee","year":"2024","unstructured":"Robblee J, et al. Nonspecific oral medications versus anti-calcitonin gene-related peptide monoclonal antibodies for migraine: a systematic review and meta-analysis of randomized controlled trials. Headache. 2024;64(5):547\u201372.","journal-title":"Headache"},{"key":"1387_CR40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.expneurol.2015.05.005","volume":"271","author":"M Romero-Reyes","year":"2015","unstructured":"Romero-Reyes M, Pardi V, Akerman S. A potent and selective calcitonin gene-related peptide (CGRP) receptor antagonist, MK-8825, inhibits responses to nociceptive trigeminal activation: role of CGRP in orofacial pain. Exp Neurol. 2015;271:95\u2013103.","journal-title":"Exp Neurol"},{"issue":"3","key":"1387_CR41","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1212\/CPJ.0000000000001075","volume":"11","author":"E Parascandolo","year":"2021","unstructured":"Parascandolo E, et al. Efficacy of erenumab in the treatment of trigeminal neuralgia: a retrospective case series. Neurol Clin Pract. 2021;11(3):227\u201331.","journal-title":"Neurol Clin Pract"},{"issue":"3","key":"1387_CR42","first-page":"e35913","volume":"15","author":"M Katsuki","year":"2023","unstructured":"Katsuki M, et al. Erenumab in the treatment of comorbid trigeminal neuralgia in patients with migraine. Cureus. 2023;15(3):e35913.","journal-title":"Cureus"},{"issue":"11","key":"1387_CR43","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/S1474-4422(22)00294-0","volume":"21","author":"AS Schott Andersen","year":"2022","unstructured":"Schott Andersen AS, et al. Safety and efficacy of erenumab in patients with trigeminal neuralgia in Denmark: a double-blind, randomised, placebo-controlled, proof-of-concept study. Lancet Neurol. 2022;21(11):994\u20131003.","journal-title":"Lancet Neurol"},{"issue":"8","key":"1387_CR44","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/01.ajp.0000210917.18536.0d","volume":"22","author":"A Kanai","year":"2006","unstructured":"Kanai A, et al. Sumatriptan alleviates pain in patients with trigeminal neuralgia. Clin J Pain. 2006;22(8):677\u201380.","journal-title":"Clin J Pain"},{"issue":"4","key":"1387_CR45","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1526-4610.2006.00405.x","volume":"46","author":"A Kanai","year":"2006","unstructured":"Kanai A, Saito M, Hoka S. Subcutaneous sumatriptan for refractory trigeminal neuralgia. Headache. 2006;46(4):577\u201382.","journal-title":"Headache"},{"issue":"5","key":"1387_CR46","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1526-4610.2008.01254.x","volume":"49","author":"K Shimohata","year":"2009","unstructured":"Shimohata K, et al. Nasal sumatriptan as adjunctive therapy for idiopathic trigeminal neuralgia: report of three cases. Headache. 2009;49(5):768\u201370.","journal-title":"Headache"},{"issue":"5","key":"1387_CR47","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/pme.12349","volume":"15","author":"Y Niki","year":"2014","unstructured":"Niki Y, et al. Immediate analgesic effect of 8% lidocaine applied to the oral mucosa in patients with trigeminal neuralgia. Pain Med. 2014;15(5):826\u201331.","journal-title":"Pain Med"},{"issue":"1","key":"1387_CR48","first-page":"159","volume":"77","author":"R Spaziante","year":"1992","unstructured":"Spaziante R, et al. Treatment of trigeminal neuralgia by ophthalmic anesthetic. J Neurosurg. 1992;77(1):159\u201360.","journal-title":"J Neurosurg"},{"issue":"4","key":"1387_CR49","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/bja\/ael180","volume":"97","author":"A Kanai","year":"2006","unstructured":"Kanai A, et al. Intranasal lidocaine 8% spray for second-division trigeminal neuralgia. Br J Anaesth. 2006;97(4):559\u201363.","journal-title":"Br J Anaesth"},{"issue":"4","key":"1387_CR50","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/1756285615583202","volume":"8","author":"A Vargas","year":"2015","unstructured":"Vargas A, Thomas K. Intravenous fosphenytoin for acute exacerbation of trigeminal neuralgia: case report and literature review. Ther Adv Neurol Disord. 2015;8(4):187\u20138.","journal-title":"Ther Adv Neurol Disord"},{"issue":"10","key":"1387_CR51","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1177\/03331024221092435","volume":"42","author":"A Munoz-Vendrell","year":"2022","unstructured":"Munoz-Vendrell A, et al. Intravenous lacosamide and phenytoin for the treatment of acute exacerbations of trigeminal neuralgia: a retrospective analysis of 144 cases. Cephalalgia. 2022;42(10):1031\u20138.","journal-title":"Cephalalgia"},{"issue":"3","key":"1387_CR52","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1080\/00325481.2022.2035092","volume":"134","author":"H Soleimanpour","year":"2022","unstructured":"Soleimanpour H, et al. Management of pain using magnesium sulphate: a narrative review. Postgrad Med. 2022;134(3):260\u20136.","journal-title":"Postgrad Med"},{"issue":"6","key":"1387_CR53","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1007\/s00540-013-1641-5","volume":"27","author":"YC Arai","year":"2013","unstructured":"Arai YC, et al. Intravenous lidocaine and magnesium for management of intractable trigeminal neuralgia: a case series of nine patients. J Anesth. 2013;27(6):960\u20132.","journal-title":"J Anesth"},{"key":"1387_CR54","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jns.2016.09.017","volume":"371","author":"M Xu","year":"2016","unstructured":"Xu M, et al. Efficacy of intravenous lidocaine and magnesium in intractable trigeminal neuralgia: a preliminary report. J Neurol Sci. 2016;371:149\u201351.","journal-title":"J Neurol Sci"},{"issue":"2","key":"1387_CR55","doi-asserted-by":"publisher","first-page":"E235","DOI":"10.36076\/ppj.2014\/17\/E235","volume":"17","author":"E Stavropoulou","year":"2014","unstructured":"Stavropoulou E, Zis P, Vadalouca A. The use of intravenous lidocaine in trigeminal neuralgia pain relief and palliative care unit. Pain Physician. 2014;17(2):E235\u20136.","journal-title":"Pain Physician"},{"key":"1387_CR56","doi-asserted-by":"publisher","first-page":"1202426","DOI":"10.3389\/fneur.2023.1202426","volume":"14","author":"CF Mullins","year":"2023","unstructured":"Mullins CF, et al. A single infusion of intravenous lidocaine for primary headaches and trigeminal neuralgia: a retrospective analysis. Front Neurol. 2023;14:1202426.","journal-title":"Front Neurol"},{"issue":"6","key":"1387_CR57","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1212\/WNL.43.6.1233","volume":"43","author":"BS Galer","year":"1993","unstructured":"Galer BS, Miller KV, Rowbotham MC. Response to intravenous lidocaine infusion differs based on clinical diagnosis and site of nervous system injury. Neurology. 1993;43(6):1233\u20135.","journal-title":"Neurology"},{"issue":"8","key":"1387_CR58","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1111\/head.12401","volume":"54","author":"P Chaudhry","year":"2014","unstructured":"Chaudhry P, Friedman DI. Intravenous lidocaine treatment in classical trigeminal neuralgia with concomitant persistent facial pain. Headache. 2014;54(8):1376\u20139.","journal-title":"Headache"},{"key":"1387_CR59","doi-asserted-by":"publisher","first-page":"853826","DOI":"10.1155\/2014\/853826","volume":"2014","author":"E Stavropoulou","year":"2014","unstructured":"Stavropoulou E, et al. The effect of intravenous lidocaine on trigeminal neuralgia: a randomized double blind placebo controlled trial. ISRN Pain. 2014;2014:853826.","journal-title":"ISRN Pain"},{"issue":"8","key":"1387_CR60","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1590\/0004-282X20150077","volume":"73","author":"F Di Stani","year":"2015","unstructured":"Di Stani F, et al. Combination of pharmacotherapy and lidocaine analgesic block of the peripheral trigeminal branches for trigeminal neuralgia: a pilot study. Arq Neuropsiquiatr. 2015;73(8):660\u20134.","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"1387_CR61","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0304-3959(98)00156-0","volume":"79","author":"F Goto","year":"1999","unstructured":"Goto F, et al. The long lasting effects of peripheral nerve blocks for trigeminal neuralgia using high concentration of tetracaine dissolved in bupivacaine. Pain. 1999;79(1):101\u20133.","journal-title":"Pain"},{"issue":"6","key":"1387_CR62","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3340\/jkns.2020.0139","volume":"63","author":"HJ Seo","year":"2020","unstructured":"Seo HJ, et al. Clinical outcome of percutaneous trigeminal nerve block in elderly patients in outpatient clinics. J Korean Neurosurg Soc. 2020;63(6):814\u201320.","journal-title":"J Korean Neurosurg Soc"},{"issue":"2","key":"1387_CR63","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1742-1241.2007.01568.x","volume":"62","author":"KR Han","year":"2008","unstructured":"Han KR, et al. Efficacy and safety of high concentration lidocaine for trigeminal nerve block in patients with trigeminal neuralgia. Int J Clin Pract. 2008;62(2):248\u201354.","journal-title":"Int J Clin Pract"},{"issue":"11","key":"1387_CR64","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1016\/j.ajem.2018.08.019","volume":"36","author":"MD Perloff","year":"2018","unstructured":"Perloff MD, Chung JS. Urgent care peripheral nerve blocks for refractory trigeminal neuralgia. Am J Emerg Med. 2018;36(11):2058\u201360.","journal-title":"Am J Emerg Med"},{"issue":"2","key":"1387_CR65","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/scd.12365","volume":"39","author":"M Gornitsky","year":"2019","unstructured":"Gornitsky M, et al. Greater palatine block for V2 trigeminal neuralgia: case report. Spec Care Dentist. 2019;39(2):208\u201313.","journal-title":"Spec Care Dentist"},{"issue":"2","key":"1387_CR66","doi-asserted-by":"publisher","first-page":"135","DOI":"10.11607\/ofph.2510","volume":"34","author":"K Yoshida","year":"2020","unstructured":"Yoshida K. Sphenopalatine ganglion block with botulinum neurotoxin for treating trigeminal neuralgia using CAD\/CAM-derived injection guide. J Oral Facial Pain Headache. 2020;34(2):135\u201340.","journal-title":"J Oral Facial Pain Headache"},{"issue":"1","key":"1387_CR67","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s10194-016-0651-8","volume":"17","author":"ME Morra","year":"2016","unstructured":"Morra ME, et al. Therapeutic efficacy and safety of botulinum toxin A therapy in trigeminal neuralgia: a systematic review and meta-analysis of randomized controlled trials. J Headache Pain. 2016;17(1):63.","journal-title":"J Headache Pain"},{"issue":"1","key":"1387_CR68","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1129-2377-14-92","volume":"14","author":"HS Shehata","year":"2013","unstructured":"Shehata HS, et al. Botulinum toxin-type A: could it be an effective treatment option in intractable trigeminal neuralgia? J Headache Pain. 2013;14(1):92.","journal-title":"J Headache Pain"},{"issue":"5","key":"1387_CR69","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/WNF.0b013e31829cb60e","volume":"36","author":"C Zuniga","year":"2013","unstructured":"Zuniga C, et al. Acute treatment of trigeminal neuralgia with onabotulinum toxin A. Clin Neuropharmacol. 2013;36(5):146\u201350.","journal-title":"Clin Neuropharmacol"},{"issue":"6","key":"1387_CR70","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1177\/0333102412441721","volume":"32","author":"CJ Wu","year":"2012","unstructured":"Wu CJ, et al. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial. Cephalalgia. 2012;32(6):443\u201350.","journal-title":"Cephalalgia"},{"issue":"2","key":"1387_CR71","first-page":"e2","volume":"11","author":"A Rubis","year":"2020","unstructured":"Rubis A, Juodzbalys G. The use of botulinum toxin A in the management of trigeminal neuralgia: a systematic literature review. J Oral Maxillofac Res. 2020;11(2):e2.","journal-title":"J Oral Maxillofac Res"},{"issue":"8","key":"1387_CR72","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1111\/head.13608","volume":"59","author":"J Crespi","year":"2019","unstructured":"Crespi J, et al. Pilot study of injection of OnabotulinumtoxinA toward the sphenopalatine ganglion for the treatment of classical trigeminal neuralgia. Headache. 2019;59(8):1229\u201339.","journal-title":"Headache"},{"issue":"8","key":"1387_CR73","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/archneur.59.8.1297","volume":"59","author":"PV Theodosopoulos","year":"2002","unstructured":"Theodosopoulos PV, et al. Predictive model for pain recurrence after posterior fossa surgery for trigeminal neuralgia. Arch Neurol. 2002;59(8):1297\u2013302.","journal-title":"Arch Neurol"},{"issue":"6","key":"1387_CR74","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1227\/01.NEU.0000065129.25359.EE","volume":"52","author":"SN Kalkanis","year":"2003","unstructured":"Kalkanis SN, et al. Microvascular decompression surgery in the United States, 1996 to 2000: mortality rates, morbidity rates, and the effects of hospital and surgeon volumes. Neurosurg. 2003;52(6):1251\u201361.","journal-title":"Neurosurg"},{"issue":"2","key":"1387_CR75","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3171\/2011.4.JNS101924","volume":"115","author":"AI Rughani","year":"2011","unstructured":"Rughani AI, et al. Safety of microvascular decompression for trigeminal neuralgia in the elderly. Clinical article. J Neurosurg. 2011;115(2):202\u20139.","journal-title":"J Neurosurg"},{"issue":"19","key":"1387_CR76","doi-asserted-by":"publisher","first-page":"7012","DOI":"10.3390\/ijerph17197012","volume":"17","author":"R Gerwin","year":"2020","unstructured":"Gerwin R. Chronic facial pain: trigeminal neuralgia, persistent idiopathic facial pain, and myofascial pain syndrome-an evidence-based narrative review and etiological hypothesis. Int J Environ Res Public Health. 2020;17(19):7012.","journal-title":"Int J Environ Res Public Health"},{"issue":"12","key":"1387_CR77","doi-asserted-by":"publisher","first-page":"e14148","DOI":"10.1002\/acm2.14148","volume":"24","author":"T Neupane","year":"2023","unstructured":"Neupane T, et al. Viability of the virtual cone technique using a fixed small multi-leaf collimator field for stereotactic radiosurgery of trigeminal neuralgia. J Appl Clin Med Phys. 2023;24(12):e14148.","journal-title":"J Appl Clin Med Phys"},{"issue":"2","key":"1387_CR78","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3349\/ymj.2020.61.2.111","volume":"61","author":"SH Park","year":"2020","unstructured":"Park SH, Chang JW. Gamma knife radiosurgery on the trigeminal root entry zone for idiopathic trigeminal neuralgia: results and a review of the literature. Yonsei Med J. 2020;61(2):111\u20139.","journal-title":"Yonsei Med J"},{"key":"1387_CR79","doi-asserted-by":"publisher","first-page":"e593","DOI":"10.1016\/j.wneu.2017.11.062","volume":"110","author":"Y Wang","year":"2018","unstructured":"Wang Y, et al. Gamma knife surgery for recurrent trigeminal neuralgia in cases with previous microvascular decompression. World Neurosurg. 2018;110:e593\u20138.","journal-title":"World Neurosurg"},{"issue":"3","key":"1387_CR80","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3171\/2017.9.JNS17545","volume":"130","author":"C Tuleasca","year":"2018","unstructured":"Tuleasca C, et al. Stereotactic radiosurgery for trigeminal neuralgia: a systematic review. J Neurosurg. 2018;130(3):733\u201357.","journal-title":"J Neurosurg"},{"issue":"8","key":"1387_CR81","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1046\/j.1365-2044.1999.00905.x","volume":"54","author":"KB Yoon","year":"1999","unstructured":"Yoon KB, et al. Long-term outcome of percutaneous thermocoagulation for trigeminal neuralgia. Anaesthesia. 1999;54(8):803\u20138.","journal-title":"Anaesthesia"},{"key":"1387_CR82","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.4103\/ijpn.ijpn_119_22","volume":"36","author":"A Agarwal","year":"2022","unstructured":"Agarwal A, Singh RS, Singh N, Litin MK, Bhasin Y. Percutaneous treatment of trigeminal neuralgia: a narrative review. Indian J Pain. 2022;36:S31\u20139.","journal-title":"Indian J Pain"},{"issue":"7","key":"1387_CR83","doi-asserted-by":"publisher","first-page":"e688","DOI":"10.1097\/SCS.0000000000002971","volume":"27","author":"X Zhang","year":"2016","unstructured":"Zhang X, et al. Comparison of the efficacy of reoperation, percutaneous radiofrequency thermocoagulation when microvascular decompression of trigeminal neuralgia is invalid. J Craniofac Surg. 2016;27(7):e688\u201390.","journal-title":"J Craniofac Surg"},{"issue":"32","key":"1387_CR84","doi-asserted-by":"publisher","first-page":"e1176","DOI":"10.1097\/MD.0000000000001176","volume":"94","author":"GH Lai","year":"2015","unstructured":"Lai GH, et al. CT-guided percutaneous radiofrequency thermocoagulation for recurrent trigeminal neuralgia after microvascular decompression: a cohort study. Med (Baltim). 2015;94(32):e1176.","journal-title":"Med (Baltim)"},{"issue":"1\u20132","key":"1387_CR85","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000357868","volume":"72","author":"YZ Tang","year":"2014","unstructured":"Tang YZ, et al. Repeated CT-guided percutaneous radiofrequency thermocoagulation for recurrent trigeminal neuralgia. Eur Neurol. 2014;72(1\u20132):54\u20139.","journal-title":"Eur Neurol"},{"issue":"4","key":"1387_CR86","first-page":"1","volume":"131","author":"DP Patra","year":"2018","unstructured":"Patra DP, et al. Repeat gamma knife radiosurgery versus microvascular decompression following failure of GKRS in trigeminal neuralgia: a systematic review and meta-analysis. J Neurosurg. 2018;131(4):1\u201310.","journal-title":"J Neurosurg"},{"issue":"25","key":"1387_CR87","doi-asserted-by":"publisher","first-page":"e29543","DOI":"10.1097\/MD.0000000000029543","volume":"101","author":"CC Yang","year":"2022","unstructured":"Yang CC, et al. Percutaneous radiofrequency trigeminal rhizotomy benefits in patients with refractory trigeminal neuralgia. Med (Baltim). 2022;101(25):e29543.","journal-title":"Med (Baltim)"},{"issue":"6","key":"1387_CR88","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.3171\/2020.10.JNS202323","volume":"135","author":"M Gupta","year":"2021","unstructured":"Gupta M, et al. Results of three or more gamma knife radiosurgery procedures for recurrent trigeminal neuralgia. J Neurosurg. 2021;135(6):1789\u201398.","journal-title":"J Neurosurg"},{"key":"1387_CR89","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.wneu.2024.02.097","volume":"185","author":"AR Rheaume","year":"2024","unstructured":"Rheaume AR, et al. Repeat surgery for recurrent or refractory trigeminal neuralgia: a systematic review and Meta-analysis. World Neurosurg. 2024;185:370\u201380.","journal-title":"World Neurosurg"},{"issue":"5","key":"1387_CR90","doi-asserted-by":"publisher","first-page":"828","DOI":"10.3171\/jns.1999.90.5.0828","volume":"90","author":"HA Wilkinson","year":"1999","unstructured":"Wilkinson HA. Trigeminal nerve peripheral branch phenol\/glycerol injections for tic douloureux. J Neurosurg. 1999;90(5):828\u201332.","journal-title":"J Neurosurg"},{"issue":"10","key":"1387_CR91","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1053\/joms.2001.26721","volume":"59","author":"E Erdem","year":"2001","unstructured":"Erdem E, Alkan A. Peripheral glycerol injections in the treatment of idiopathic trigeminal neuralgia: retrospective analysis of 157 cases. J Oral Maxillofac Surg. 2001;59(10):1176\u201380.","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"1387_CR92","doi-asserted-by":"publisher","first-page":"E10","DOI":"10.3171\/2013.7.FOCUS13228","volume":"35","author":"A Feletti","year":"2013","unstructured":"Feletti A, et al. Peripheral trigeminal nerve field stimulation: report of 6 cases. Neurosurg Focus. 2013;35(3):E10.","journal-title":"Neurosurg Focus"},{"issue":"1","key":"1387_CR93","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3171\/2014.12.JNS14645","volume":"123","author":"JA Ellis","year":"2015","unstructured":"Ellis JA, Mejia Munne JC, Winfree CJ. Trigeminal branch stimulation for the treatment of intractable craniofacial pain. J Neurosurg. 2015;123(1):283\u20138.","journal-title":"J Neurosurg"},{"issue":"6","key":"1387_CR94","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/ner.13132","volume":"23","author":"RW Bina","year":"2020","unstructured":"Bina RW, et al. Peripheral nerve stimulation for refractory trigeminal pain: recent single-institution case series with long-term follow-up and review of the literature. Neuromodulation. 2020;23(6):796\u2013804.","journal-title":"Neuromodulation"},{"issue":"2","key":"1387_CR95","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1525-1403.2009.00201.x","volume":"12","author":"C Reverberi","year":"2009","unstructured":"Reverberi C, Bonezzi C, Demartini L. Peripheral subcutaneous neurostimulation in the management of neuropathic pain: five case reports. Neuromodulation. 2009;12(2):146\u201355.","journal-title":"Neuromodulation"},{"issue":"8","key":"1387_CR96","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.neurom.2022.03.012","volume":"26","author":"A Balossier","year":"2023","unstructured":"Balossier A, et al. Occipital nerve stimulation for recurrent trigeminal neuralgia without occipital pain. Neuromodulation. 2023;26(8):1795\u2013801.","journal-title":"Neuromodulation"},{"issue":"3","key":"1387_CR97","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1093\/pm\/pnac120","volume":"24","author":"AM Mansano","year":"2023","unstructured":"Mansano AM, et al. New trigeminal stimulation technique with dorsal root ganglion stimulation electrode and maxillary fixation: technique description. Pain Med. 2023;24(3):300\u20135.","journal-title":"Pain Med"},{"issue":"6","key":"1387_CR98","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1136\/jnnp.2004.055806","volume":"76","author":"EM Khedr","year":"2005","unstructured":"Khedr EM, et al. Longlasting antalgic effects of daily sessions of repetitive transcranial magnetic stimulation in central and peripheral neuropathic pain. J Neurol Neurosurg Psychiatry. 2005;76(6):833\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"1387_CR99","first-page":"126","volume":"13","author":"S Freigang","year":"2023","unstructured":"Freigang S, et al. Twenty-three months repetitive transcranial magnetic stimulation of the primary motor cortex for refractory trigeminal neuralgia: a single-case study. Life (Basel). 2023;13(1):126.","journal-title":"Life (Basel)"},{"issue":"3","key":"1387_CR100","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1097\/YCT.0000000000000595","volume":"35","author":"J Hanna","year":"2019","unstructured":"Hanna J, et al. Case report: repetitive transcranial magnetic stimulation for comorbid treatment-resistant depression and trigeminal neuralgia. J ECT. 2019;35(3):e37\u20138.","journal-title":"J ECT"},{"key":"1387_CR101","doi-asserted-by":"publisher","first-page":"848347","DOI":"10.3389\/fnhum.2022.848347","volume":"16","author":"B Babakhani","year":"2022","unstructured":"Babakhani B, et al. A preliminary study of the efficacy of transcranial direct current stimulation in trigeminal neuralgia. Front Hum Neurosci. 2022;16:848347.","journal-title":"Front Hum Neurosci"},{"key":"1387_CR102","doi-asserted-by":"publisher","first-page":"e829","DOI":"10.1016\/j.wneu.2021.11.068","volume":"158","author":"V Sabourin","year":"2022","unstructured":"Sabourin V, et al. Internal Neurolysis for the treatment of trigeminal neuralgia: a systematic review. World Neurosurg. 2022;158:e829\u201342.","journal-title":"World Neurosurg"},{"key":"1387_CR103","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.wneu.2023.08.126","volume":"184","author":"P Lavergne","year":"2024","unstructured":"Lavergne P, et al. Internal neurolysis for trigeminal neuralgia: technical nuances and a single-institution experience. World Neurosurg. 2024;184:e9\u201316.","journal-title":"World Neurosurg"},{"issue":"3","key":"1387_CR104","doi-asserted-by":"publisher","first-page":"300060522108072","DOI":"10.1177\/03000605221080721","volume":"50","author":"B Wang","year":"2022","unstructured":"Wang B, Zhang L, Yu Y. Treatment of redo-microvascular decompression or internal neurolysis plus microvascular decompression for recurrent trigeminal neuralgia: a review of long-term effectiveness and safety. J Int Med Res. 2022;50(3):3000605221080721.","journal-title":"J Int Med Res"},{"issue":"6","key":"1387_CR105","doi-asserted-by":"publisher","first-page":"966","DOI":"10.3340\/jkns.2020.0315","volume":"64","author":"W Zheng","year":"2021","unstructured":"Zheng W, et al. Long time efficacy and safety of microvascular decompression combined with internal neurolysis for recurrent trigeminal neuralgia. J Korean Neurosurg Soc. 2021;64(6):966\u201374.","journal-title":"J Korean Neurosurg Soc"},{"issue":"2","key":"1387_CR106","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1080\/02688697.2020.1837730","volume":"36","author":"AJ Durnford","year":"2022","unstructured":"Durnford AJ, et al. Internal neurolysis: \u2018nerve combing\u2019 for trigeminal neuralgia without neurovascular conflict - early UK outcomes. Br J Neurosurg. 2022;36(2):175\u20138.","journal-title":"Br J Neurosurg"},{"issue":"4","key":"1387_CR107","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1055\/s-0041-1723809","volume":"82","author":"MW Li","year":"2021","unstructured":"Li MW, Jiang XF, Niu C. Efficacy of internal neurolysis for trigeminal neuralgia without vascular compression. J Neurol Surg Cent Eur Neurosurg. 2021;82(4):364\u20138.","journal-title":"J Neurol Surg Cent Eur Neurosurg"},{"issue":"8","key":"1387_CR108","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1016\/j.asjsur.2024.04.139","volume":"47","author":"K Zhang","year":"2024","unstructured":"Zhang K, et al. Efficacy of internal neurolysis combined with microvascular decompression surgery in special types of trigeminal neuralgia. Asian J Surg. 2024;47(8):3809\u201310.","journal-title":"Asian J Surg"},{"key":"1387_CR109","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mri.2020.05.006","volume":"71","author":"M Wu","year":"2020","unstructured":"Wu M, et al. Diffusion tensor imaging reveals microstructural alteration of the trigeminal nerve root in classical trigeminal neuralgia without neurovascular compression and correlation with outcome after internal neurolysis. Magn Reson Imaging. 2020;71:37\u201344.","journal-title":"Magn Reson Imaging"},{"issue":"1","key":"1387_CR110","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.surneu.2005.10.018","volume":"66","author":"R Revuelta-Gutierrez","year":"2006","unstructured":"Revuelta-Gutierrez R, Lopez-Gonzalez MA, Soto-Hernandez JL. Surgical treatment of trigeminal neuralgia without vascular compression: 20 years of experience. Surg Neurol. 2006;66(1):32\u20136.","journal-title":"Surg Neurol"},{"issue":"1","key":"1387_CR111","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12893-022-01469-3","volume":"22","author":"J Li","year":"2022","unstructured":"Li J, et al. Neurapraxia in patients with trigeminal neuralgia but no identifiable neurovascular conflict during microvascular decompression: a retrospective analysis of 26 cases. BMC Surg. 2022;22(1):13.","journal-title":"BMC Surg"},{"key":"1387_CR112","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1016\/j.wneu.2018.05.211","volume":"117","author":"LM Terrier","year":"2018","unstructured":"Terrier LM, et al. Therapeutic failure in trigeminal neuralgia: from a clarification of trigeminal nerve somatotopy to a targeted partial sensory rhizotomy. World Neurosurg. 2018;117:e138\u201345.","journal-title":"World Neurosurg"},{"issue":"1","key":"1387_CR113","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10143-024-02463-4","volume":"47","author":"MP Sousa","year":"2024","unstructured":"Sousa MP, et al. Efficacy and safety of microvascular decompression with or without partial sensory rhizotomy: a comprehensive meta-analysis and systematic review in treating trigeminal neuralgia. Neurosurg Rev. 2024;47(1):229.","journal-title":"Neurosurg Rev"},{"issue":"6","key":"1387_CR114","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1227\/01.NEU.0000159883.35957.E0","volume":"56","author":"JM Zakrzewska","year":"2005","unstructured":"Zakrzewska JM, et al. Patient reports of satisfaction after microvascular decompression and partial sensory rhizotomy for trigeminal neuralgia. Neurosurg. 2005;56(6):1304\u201311.","journal-title":"Neurosurg"},{"issue":"11","key":"1387_CR115","doi-asserted-by":"publisher","first-page":"e3264","DOI":"10.1097\/GOX.0000000000003264","volume":"8","author":"F Ferri","year":"2020","unstructured":"Ferri F, et al. Peripheral neurectomy for management of trigeminal neuralgia refractory to multiple surgical procedures. Plast Reconstr Surg Glob Open. 2020;8(11):e3264.","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"9","key":"1387_CR116","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.bjoms.2020.08.073","volume":"58","author":"A Goss","year":"2020","unstructured":"Goss A, Ito K. Cryoneurotomy in the management of intractable trigeminal neuralgia. Br J Oral Maxillofac Surg. 2020;58(9):1187\u201392.","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"1","key":"1387_CR117","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/0266-4356(88)90145-3","volume":"26","author":"JM Zakrzewska","year":"1988","unstructured":"Zakrzewska JM, Nally FF. The role of cryotherapy (cryoanalgesia) in the management of paroxysmal trigeminal neuralgia: a six year experience. Br J Oral Maxillofac Surg. 1988;26(1):18\u201325.","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"8","key":"1387_CR118","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s11916-022-01066-2","volume":"26","author":"M Gupta","year":"2022","unstructured":"Gupta M, et al. Cervical spinal cord stimulation for trigeminal neuralgia: a narrative review. Curr Pain Headache Rep. 2022;26(8):639\u201345.","journal-title":"Curr Pain Headache Rep"},{"key":"1387_CR119","doi-asserted-by":"publisher","first-page":"198","DOI":"10.25259\/SNI_60_2023","volume":"14","author":"BM Edelbach","year":"2023","unstructured":"Edelbach BM, Lopez-Gonzalez MA. Percutaneous high cervical spinal cord stimulation for refractory trigeminal neuralgia. Surg Neurol Int. 2023;14:198.","journal-title":"Surg Neurol Int"},{"issue":"1","key":"1387_CR120","first-page":"52","volume":"77","author":"MA Kolodziej","year":"2016","unstructured":"Kolodziej MA, et al. Treatment of central deafferentation and trigeminal neuropathic pain by motor cortex stimulation: report of a series of 20 patients. J Neurol Surg Cent Eur Neurosurg. 2016;77(1):52\u20138.","journal-title":"J Neurol Surg Cent Eur Neurosurg"},{"issue":"5","key":"1387_CR121","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1227\/NEU.0000000000001353","volume":"79","author":"D Rasche","year":"2016","unstructured":"Rasche D, Tronnier VM. Clinical significance of invasive motor cortex stimulation for trigeminal facial neuropathic pain syndromes. Neurosurg. 2016;79(5):655\u201366.","journal-title":"Neurosurg"},{"issue":"1","key":"1387_CR122","doi-asserted-by":"publisher","first-page":"e0191774","DOI":"10.1371\/journal.pone.0191774","volume":"13","author":"D Henssen","year":"2018","unstructured":"Henssen D, et al. Long-term effect of motor cortex stimulation in patients suffering from chronic neuropathic pain: an observational study. PLoS ONE. 2018;13(1):e0191774.","journal-title":"PLoS ONE"},{"issue":"1","key":"1387_CR123","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12883-019-1273-y","volume":"19","author":"JJ Mo","year":"2019","unstructured":"Mo JJ, et al. Motor cortex stimulation: a systematic literature-based analysis of effectiveness and case series experience. BMC Neurol. 2019;19(1):48.","journal-title":"BMC Neurol"},{"issue":"2","key":"1387_CR124","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000323338","volume":"89","author":"AM Raslan","year":"2011","unstructured":"Raslan AM, et al. Motor cortex stimulation for trigeminal neuropathic or deafferentation pain: an institutional case series experience. Stereotact Funct Neurosurg. 2011;89(2):83\u20138.","journal-title":"Stereotact Funct Neurosurg"},{"key":"1387_CR125","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1159\/000509909","volume":"35","author":"ZE Teton","year":"2020","unstructured":"Teton ZE, Raslan AM. Motor cortex stimulation for facial pain. Prog Neurol Surg. 2020;35:162\u20139.","journal-title":"Prog Neurol Surg"},{"issue":"1","key":"1387_CR126","first-page":"147","volume":"94","author":"JA Aibar-Duran","year":"2024","unstructured":"Aibar-Duran JA, et al. Long-term results of cortical motor stimulation for neuropathic peripheral and central pain: real-world evidence from two independent centers. Neurosurg. 2024;94(1):147\u201353.","journal-title":"Neurosurg"},{"issue":"3","key":"1387_CR127","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1046\/j.1526-4637.2001.01029.x","volume":"2","author":"RJ Coffey","year":"2001","unstructured":"Coffey RJ. Deep brain stimulation for chronic pain: results of two multicenter trials and a structured review. Pain Med. 2001;2(3):183\u201392.","journal-title":"Pain Med"},{"key":"1387_CR128","doi-asserted-by":"publisher","first-page":"1239092","DOI":"10.3389\/fneur.2023.1239092","volume":"14","author":"V Mandat","year":"2023","unstructured":"Mandat V, et al. Periaqueductal\/periventricular gray deep brain stimulation for the treatment of neuropathic facial pain. Front Neurol. 2023;14:1239092.","journal-title":"Front Neurol"},{"issue":"2","key":"1387_CR129","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.3171\/2010.5.FOCUS1094","volume":"29","author":"A Franzini","year":"2010","unstructured":"Franzini A, et al. Deep brain stimulation of the posteromedial hypothalamus: indications, long-term results, and neurophysiological considerations. Neurosurg Focus. 2010;29(2):E13.","journal-title":"Neurosurg Focus"},{"issue":"6","key":"1387_CR130","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/ana.21801","volume":"66","author":"E Martin","year":"2009","unstructured":"Martin E, et al. High-intensity focused ultrasound for noninvasive functional neurosurgery. Ann Neurol. 2009;66(6):858\u201361.","journal-title":"Ann Neurol"},{"key":"1387_CR131","doi-asserted-by":"publisher","first-page":"109688","DOI":"10.1016\/j.mehy.2020.109688","volume":"139","author":"Y Ma","year":"2020","unstructured":"Ma Y, Hsu G, Zhang F. The applicability and efficacy of magnetic resonance-guided high intensity focused ultrasound system in the treatment of primary trigeminal neuralgia. Med Hypotheses. 2020;139:109688.","journal-title":"Med Hypotheses"},{"issue":"3","key":"1387_CR132","doi-asserted-by":"publisher","first-page":"615","DOI":"10.3171\/2023.1.JNS222879","volume":"139","author":"MN Gallay","year":"2023","unstructured":"Gallay MN, et al. Magnetic resonance-guided focused ultrasound central lateral thalamotomy against chronic and therapy-resistant neuropathic pain: retrospective long-term follow-up analysis of 63 interventions. J Neurosurg. 2023;139(3):615\u201324.","journal-title":"J Neurosurg"},{"issue":"2","key":"1387_CR133","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3171\/2008.6.17602","volume":"110","author":"D Fontaine","year":"2009","unstructured":"Fontaine D, Hamani C, Lozano A. Efficacy and safety of motor cortex stimulation for chronic neuropathic pain: critical review of the literature. J Neurosurg. 2009;110(2):251\u20136.","journal-title":"J Neurosurg"},{"key":"1387_CR134","doi-asserted-by":"publisher","first-page":"1156108","DOI":"10.3389\/fpain.2023.1156108","volume":"4","author":"JC Motzkin","year":"2023","unstructured":"Motzkin JC, et al. Network targets for therapeutic brain stimulation: towards personalized therapy for pain. Front Pain Res (Lausanne). 2023;4:1156108.","journal-title":"Front Pain Res (Lausanne)"},{"issue":"4","key":"1387_CR135","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S1015-9584(09)60404-8","volume":"32","author":"DT Chan","year":"2009","unstructured":"Chan DT, et al. Complications of deep brain stimulation: a collective review. Asian J Surg. 2009;32(4):258\u201363.","journal-title":"Asian J Surg"},{"issue":"24","key":"1387_CR136","doi-asserted-by":"publisher","first-page":"e2284","DOI":"10.1212\/WNL.0000000000008561","volume":"93","author":"CH Halpern","year":"2019","unstructured":"Halpern CH, et al. Three-year follow-up of prospective trial of focused ultrasound thalamotomy for essential tremor. Neurology. 2019;93(24):e2284\u201393.","journal-title":"Neurology"},{"issue":"5","key":"1387_CR137","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3171\/2014.12.JNS14469","volume":"122","author":"AL Ko","year":"2015","unstructured":"Ko AL, et al. Long-term efficacy and safety of internal neurolysis for trigeminal neuralgia without neurovascular compression. J Neurosurg. 2015;122(5):1048\u201357.","journal-title":"J Neurosurg"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-024-01387-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-024-01387-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-024-01387-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T10:04:44Z","timestamp":1733997884000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-024-01387-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,12]]},"references-count":137,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1387"],"URL":"https:\/\/doi.org\/10.1007\/s11910-024-01387-2","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,12]]},"assertion":[{"value":"24 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent\u00a0"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Dr. Stern is a shareholder in Emmyon, Inc., which has no relevance to any portion of  the manuscript.Dr. Chiang has served as a consultant for Satsuma pharmaceuticals and eNeura.  She has received research support from the American Heart Association, with funds  paid to her institution.Dr Ali has no disclosures.Dr. Robertson has served on an advisory board for Satsuma and Linpharma  pharmaceuticals. She has received research support from Pfizer, Lundbeck, and  Teva, with funds paid to her institution.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statements and Declarations"}}],"article-number":"10"}}